转自：前瞻产业研究院 口腔种植产业链上游原材料与核心部件供应商主要有爱尔创、康拓医疗、国瓷材料、正海生物、奥精医 疗等;设备制造商主要有美亚光电、爱迪特等;软件开发商主要有阳普医疗等。产业链中游种植体生产商 主要有通策医疗、正海生物、康拓医疗等企业;器械经销商主要有国药控股、上海医药等旗下器械分销 平台。产业链下游医疗机构主要包络瑞尔集团、牙博士口腔、美奥口腔等。 行业主要上市公司：通策医疗(600763)、奥精医疗(688613)、瑞尔集团(6639.HK)、牙博士(874689)、可 恩口腔(830938)、蓝天口腔(873101)、华齿口腔(873311)、华美牙科(833269)等 本文核心数据：口腔种植行业全产业链;区域热力图;代表性企业产业链布局 1、中国口腔种植产业链全景梳理 从产业链结构来看，口腔种植产业链上游主要包括原材料与核心部件供应商、设备制造商以及软件开发 商。其中原材料主要包括金属材料，如提供钛及钛合金的厂商，这是种植体的主要材料，因其具有良好 的生物相容性和机械性能;还有陶瓷材料供应商，如生产氧化锆、生物玻璃陶瓷等的厂商，这些材料常 用于制作牙冠等修复体;此外，提供其他生物降解材料 ...

近日,省工业和信息化厅公布了2025年全省质量标杆典型经验名单,日照高新区山东华车能源科技有限公 司、山东迈尔医疗科技有限公司2家企业的管理经验成功入选。 下一步,高新区将持续深耕质量标杆培育工作,筑牢质量发展的坚实根基,通过以技术创新为引擎驱动质量 升级,凭借"智"造赋能"质"效提升,聚力培育新质生产力,全力推动全区制造业向更高水平、更高质量迈 进。 质量标杆典型经验是指企业通过技术创新、管理创新和商业模式创新,运用先进适用的质量管理方法和 质量工程技术,在系统提升产品和服务质量的实践过程中,形成的具有示范效应、可借鉴、可推广的典型 经验。发挥质量标准品牌赋值作用、提升质量保障能力和水平,是增强企业核心竞争力,推动工业高端 化、智能化、绿色化发展的有力支撑。 山东华车能源科技有限公司通过实施"基于精益管理模式的新能源机车'绿色智造'质量提升创新实践",将 精益管理理念贯穿于新能源机车研发设计、生产制造、采购供应等全过程,通过消除浪费、优化流程、 提高效率,实现质量提升和成本降低。并将绿色环保理念融入新能源机车的研发和制造过程中,通过采用 节能技术等措施,降低机车的能耗和排放,实现可持续发展。 山东迈尔医疗科 ...

Group 1 - The core viewpoint of the articles highlights the recent performance and financial metrics of Aojing Medical, including its stock price increase and market valuation [1] - As of March 31, 2025, Aojing Medical has 7,905 shareholders, a decrease of 232 from the previous period, with an average holding value of 352,800 yuan and an average shareholding of 27,600 shares [1] - Aojing Medical specializes in high-end biomedical materials and related medical device products, with key products including BONGOLD, single-tooth anti-rotation abutments, and oral implants [1] Group 2 - The latest financial report for Q1 2025 shows Aojing Medical achieved revenue of 42.46 million yuan, a year-on-year decrease of 10.35%, and a net profit of 1.04 million yuan, down 84.99%, with a gross margin of 60.71% [1] - The company's current price-to-earnings (P/E) ratio is significantly negative at -150.60, with a price-to-book (P/B) ratio of 1.99, and a total market capitalization of 2.795 billion yuan [2] - The industry average P/E ratio is 51.00, while the median is 37.03, indicating Aojing Medical's valuation is below industry standards [2]

Core Insights - Songbai Dental Group has signed a cooperation agreement with Huishan Economic Development Zone, planning to invest $100 million to relocate its headquarters and listed entity to Huishan, aiming to enhance the "Yangtze River Delta Dental Valley" brand [1] - The dental healthcare market in China is projected to reach 250 billion yuan by the end of this year and is expected to grow to 500 billion yuan by 2030 [1] Industry Development - The Huishan Economic Development Zone has been focusing on the life and health industry since 2009, with a significant emphasis on dental medical devices, leading to the establishment of over 30 dental medical device companies and achieving an industry output value exceeding 3 billion yuan [2] - The establishment of the Huishan Biomedical Industry Fund, with a total scale exceeding 2.8 billion yuan, has supported 29 related biomedical enterprises with investments exceeding 580 million yuan [3] Innovation and Technology - The production processes at Angelalign, a leading company in the dental medical device sector, showcase advanced automation and innovation, contributing to its market leadership with over 40% global market share in invisible orthodontics [4] - Companies like Gaofeng Medical and Aoshimei are advancing the domestic dental market by developing comprehensive product lines and digital platforms, enhancing the overall technological landscape of the industry [5][6] Future Prospects - The IDTI Dental Innovation Medical Device Center is under construction, expected to host 50 companies and generate over 10 billion yuan in output value upon completion [7] - The collaborative environment fostered by leading companies in the Huishan area is driving the dental medical device industry towards high-end, intelligent, and international development [7][8]